Over 95% of gastric cancers originate from the cells of the stomach lining (adenocarcinoma). This guidance applies only to adenocarcinoma. Symptoms may include heartburn, dysphagia and weight loss.
Nab-paclitaxel combined with oxaliplatin and S-1 as conversion therapy for advanced gastric adenocarcinoma. Phase 2 study of cabozantinib (cabo) and pembrolizumab (pembro) in metastatic ...
Gastric cancer remains a major global health challenge, responsible for significant mortality worldwide. The human gut microbiome and its dysregulation, particularly involving Helicobacter pylori, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results